Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1999
06/16/1999EP0921774A1 Transdermal drug delivery matrix for coadministering estradiol and another steroid
06/16/1999EP0873127A4 Anthelmintic macrocyclic lactone compositions
06/16/1999EP0863897B1 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4- or h3-receptor ligands
06/16/1999EP0848736A4 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor
06/16/1999EP0827507B1 Protease inhibiting succinic acid derivatives
06/16/1999EP0804411A4 Synthetic polyunsaturated fatty acid analogues
06/16/1999EP0757690A4 Electron-deficient porphyrins and processes and intermediates for preparing same
06/16/1999EP0752424B1 Nicotinic acid derivative and herbicide
06/16/1999EP0711283B1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
06/16/1999EP0697862B1 Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders
06/16/1999EP0669976B1 Screening method using transcription factor DP-1
06/16/1999EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
06/16/1999EP0553218B1 Indole derivatives
06/16/1999EP0528922B1 New sulfonyl compounds
06/16/1999EP0316434B2 Cough/cold mixtures comprising non-sedating antihistamine drugs
06/16/1999CN2323783Y Nifedipine plaster film
06/16/1999CN2323782Y Constant release paster for metoprolol
06/16/1999CN1219969A Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same
06/16/1999CN1219968A Antibodies to ED-8 domain of fibronectin, their construction and uses
06/16/1999CN1219967A Glial cell line-derived neurotrophic factor receptor
06/16/1999CN1219965A Promotion of regeneration of organized tissues
06/16/1999CN1219939A Method and apparatus for preparing acellular red blood cell substitute
06/16/1999CN1219937A Carbohydrate derivatives and their solid-phase synthesis
06/16/1999CN1219936A New triazolopurines, method of preparing them and their use as drugs
06/16/1999CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
06/16/1999CN1219934A Novel pyridazine compounds
06/16/1999CN1219933A Novel oxazolidine derivatives, process for their production and medicaments containing them
06/16/1999CN1219932A Aromatic amidine derivatives useful as selective thrombin inhibitors
06/16/1999CN1219930A Benzoxazinone dopamine D4 receptor antagonists
06/16/1999CN1219929A Urea derivatives as inhibitors of IMPDH enzyme
06/16/1999CN1219928A Novel vitamin D analogues
06/16/1999CN1219927A Phenylalkylcarboxylic acid derivatives
06/16/1999CN1219926A Phenylthanolaminotetralin carboxamide derivatives
06/16/1999CN1219924A Colchicine-skeleton compounds, their use as medicaments and compounds containing them
06/16/1999CN1219882A Concentrated antibody preparation
06/16/1999CN1219880A Acne treatment
06/16/1999CN1219879A Pharmaceutical compositions
06/16/1999CN1219878A Method for treating pain
06/16/1999CN1219877A Method for treating pain
06/16/1999CN1219876A Method for treating migraine pain
06/16/1999CN1219875A Hexahydro-pyrido (4,3-B) indole derivatives as antipsychotic drugs
06/16/1999CN1219874A Preparation for percutaneous administration
06/16/1999CN1219873A Remedy or preventive medicine for hyperlipemia
06/16/1999CN1219872A Compositions and method for treating or preventing diseases of body passageways
06/16/1999CN1219871A Method of regulating skin appearance with vitamin B3 compound
06/16/1999CN1219865A Aqueous nacreous lustre concentrate
06/16/1999CN1219841A DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
06/16/1999CN1219541A Preparation and usage of antisense digonucleotides
06/16/1999CN1219538A Antifungal agent and its preparing process and intermediate
06/16/1999CN1219535A Process for preparing leukotrienes antagonist
06/16/1999CN1219533A Sulfonamide-substituted fused 5-membered ring compounds, their use as medicament, and pharmaceutical preparation comprising them
06/16/1999CN1219417A Medicinal composite for curing excitation confused insanity
06/16/1999CN1219393A Veterinary antiparasitic oil preparation oral liquid containing avilamycin or ivermectin
06/16/1999CN1219392A Anti-inflammatory pharmaceutical compositions
06/16/1999CN1219391A Choline antagonist sticking preparation
06/16/1999CN1219390A Novel pharmaceutical composition for control and treatment of anorectal and colonic diseases
06/16/1999CN1043645C New benzothiadiazine compound, process for its preparation and pharmaceutical compositions which contain it
06/16/1999CN1043643C Cyclohexan derivative and its use for preparing medicine
06/16/1999CN1043641C Hydroisoquinoline derivatives
06/16/1999CN1043640C Process for preparing oxazolyl derivatives
06/16/1999CN1043639C New piperidine compounds, process for their preparation and pharmaceutical compositions which contain them
06/16/1999CN1043610C Novel treatment agent
06/16/1999CN1043609C Process for preparing pharmaceutical composition containing benzothiazole compounds
06/16/1999CN1043608C Improvements in or relating to benzothiophenes
06/15/1999US5912372 Water-miscible esters of monoglycerides having antimicrobial activity
06/15/1999US5912360 Dioxolane intermediates
06/15/1999US5912357 Enzyme inhibitors
06/15/1999US5912351 Anhydrous 1,4-Dihydropyridines and salts thereof
06/15/1999US5912348 Isomerization promoted with bases
06/15/1999US5912346 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
06/15/1999US5912345 Process for the preparation of lamotrigine
06/15/1999US5912337 Parasitic helminth p22U proteins
06/15/1999US5912331 Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
06/15/1999US5912274 Water insoluble noncationic antibacterial phenol containing, relative to the hydroxyl group, an alkyl or cycloalkyl group, preferably tert.-butyl (t-butyl), in the 2-position, and substituents in one or both of the 4- and 5-positions
06/15/1999US5912273 Triphenylethylenes compositions
06/15/1999US5912272 Active substances and compositions for the therapy of senile xerosis
06/15/1999US5912271 Local anaesthetic agents, a polar lipid, a triacylglycerol and optionally water.
06/15/1999US5912270 Anti-inflammatory compounds
06/15/1999US5912268 Dosage form and method for treating incontinence
06/15/1999US5912266 6,7-anhydro-2,3,8-trideoxy-d-galacto-oct-2-enoic acid.delta.-lactone 4-acetate, also referred to as 5,6-dihydro-5(s)-acetoxy-6(s)-(1,2-trans-epoxypropyl)-2h-pyran -2-on.
06/15/1999US5912265 Administering silymarin, silybin, silidianin, silicristin, dehydrosilybin or mixtures; antitumor and anticarcinogenic agents
06/15/1999US5912264 Taxane derivatives as antitumor agents
06/15/1999US5912263 13-amino derivatives of taxanes; potent antitumor and -carcinogenic agents
06/15/1999US5912262 Heterocyclic compounds
06/15/1999US5912260 Gastrin and CCK antagonists
06/15/1999US5912259 Nonsteroid antiinflammatory agents for nervous system disorders
06/15/1999US5912257 Two-photon upconverting dyes and applications
06/15/1999US5912256 0-(4-indolyloxy)-3-(4-hydroxy-4-naphthylpiperidin-1-yl)propane s
06/15/1999US5912255 Wound healing agents for skins
06/15/1999US5912253 Rapamycin derivatives
06/15/1999US5912252 Compounds as enzyme inhibitors of purine nucleoside phosphorylase
06/15/1999US5912251 Metabolically inert anti-inflammatory and anti-tumor antifolates
06/15/1999US5912250 Use of immunosuppressive agents for the treatment of schizophrenia
06/15/1999US5912246 Treatment for schizophenia, psychosis and other psychological disorders; dopamine antagonists
06/15/1999US5912245 Ampa and kainate antagonists.
06/15/1999US5912244 Muscle disorders, breathing disorders and urinary incontinence
06/15/1999US5912242 N-(4-substituted-benzyl)-2-aminolactam derivatives
06/15/1999US5912241 Antiprotozoa agents
06/15/1999US5912240 5-androstene 3β, 17α diol as an inhibitor of tumor growth
06/15/1999US5912237 Method of synthesis of desulfated heparin and use thereof for inhibition of elastase and cathespin
1 ... 6487 6488 6489 6490 6491 6492 6493 6494 6495 6496 6497 6498 6499 6500 6501 6502 6503 6504 6505 6506 6507 ... 7860